These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2397468)

  • 1. Chromosome analysis as an aid in differential diagnosis of erythroleukemia (M6) and myelodysplasia.
    Torrabadella M; Vallespí T
    Cancer Genet Cytogenet; 1990 Oct; 49(1):139-40. PubMed ID: 2397468
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute myeloid leukemia and erythroleukemia.
    del Potro E; Krsnik I; Diaz Mediavilla J; Villegas A; Espinos D; Ferro MT
    Ann Intern Med; 1986 Feb; 104(2):281. PubMed ID: 3456219
    [No Abstract]   [Full Text] [Related]  

  • 3. [How to differentiate myelogenous leukemia FAB-type 6 (erythroleukemia) from the myelodysplastic syndrome?].
    Stavem P; Evensen SA; Brinch L; Strømsheim JP
    Tidsskr Nor Laegeforen; 1992 Aug; 112(19):2557-8. PubMed ID: 1412272
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evolution to megakaryoblastic leukemia observed in myelodysplastic syndrome with erythrolekemia-like features].
    Takai K; Sanada M; Shibuya H
    Rinsho Ketsueki; 1992 Aug; 33(8):1071-6. PubMed ID: 1404864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroleukaemia at second glance.
    Arn KD; Dazzi H; Went P; Goede JS; Stussi G
    Eur J Haematol; 2011 Apr; 86(4):358-9. PubMed ID: 21198865
    [No Abstract]   [Full Text] [Related]  

  • 6. [M6, erythroleukemia].
    Hino K; Tsuruoka N
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):77-80. PubMed ID: 9851089
    [No Abstract]   [Full Text] [Related]  

  • 7. Shifting of erythroleukemia to myelodysplastic syndrome according to the revised WHO classification: Biologic and cytogenetic features of shifted erythroleukemia.
    Ryu S; Park HS; Kim SM; Im K; Kim JA; Hwang SM; Yoon SS; Lee DS
    Leuk Res; 2018 Jul; 70():13-19. PubMed ID: 29729583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
    Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
    Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
    Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
    Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of secondary leukemia associated with (1;7)(q10;p10) in a patient with Crow-Fukase syndrome.
    Satoh K; Miura I; Chubachi A; Utsumi S; Imai H; Miura AB
    Intern Med; 1996 Aug; 35(8):660-2. PubMed ID: 8894744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplication of part of the short arm of A1 in a case of erythroleukemia (M6).
    Turchini MF; Travade P; Geneix A; de Larocque A; Beytout J; Malet P
    Pathologica; 1985; 77(1051):563-6. PubMed ID: 3870215
    [No Abstract]   [Full Text] [Related]  

  • 12. A germline ERBB3 variant is a candidate for predisposition to erythroid MDS/erythroleukemia.
    Braunstein EM; Li R; Sobreira N; Marosy B; Hetrick K; Doheny K; Gocke CD; Valle D; Brodsky RA; Cheng L
    Leukemia; 2016 Nov; 30(11):2242-2245. PubMed ID: 27416908
    [No Abstract]   [Full Text] [Related]  

  • 13. 5q-anomaly in a patient with erythroleukemia (M6-FAB classification).
    Donti E; Mecucci C; Rosetti A; Tabilio A; Venti G
    Haematologica; 1985; 70(5):424-7. PubMed ID: 3937779
    [No Abstract]   [Full Text] [Related]  

  • 14. The chromosomes in human leukemia.
    Sandberg AA
    Semin Hematol; 1986 Jul; 23(3):201-17. PubMed ID: 3462910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
    Kawakami K; Watanabe Y; Kadowaki S
    Rinsho Ketsueki; 2003 Mar; 44(3):168-73. PubMed ID: 12722343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A t(9;11)(q11;p15) translocation in a myelodysplastic syndrome with erythroleukemic trait.
    Mecucci C; Van den Berghe H; Louwagie A
    Cancer Genet Cytogenet; 1986 Nov; 23(3):281-2. PubMed ID: 3464349
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential observation of clinical and karyotypic evolution in a patient with myelodysplastic syndrome.
    Xue YQ; Guo Y; Lin BJ; Zhang GR; Lu DW; Wang MH; Gu YZ; Gong JX; Wang LX
    Chin Med J (Engl); 1989 Sep; 102(9):689-94. PubMed ID: 2517082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease.
    Goldberg SL; Noel P; Klumpp TR; Dewald GW
    Am J Clin Oncol; 1998 Feb; 21(1):42-7. PubMed ID: 9499256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling acute erythroid leukemia via CRISPR.
    Zhang JP; Cheng T
    Blood; 2021 Mar; 137(12):1565-1567. PubMed ID: 33764434
    [No Abstract]   [Full Text] [Related]  

  • 20. [Erythroleukemia - a subtype of myelodysplastic syndrome?].
    Niu Y; Chen SC; Jiang B; Li DG; Ge CW; Li RS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):219-23. PubMed ID: 17493319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.